These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6804113)
61. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients. Khan AU J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452 [TBL] [Abstract][Full Text] [Related]
62. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease. Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794 [TBL] [Abstract][Full Text] [Related]
64. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris. Frick MH; Luurila O Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362 [TBL] [Abstract][Full Text] [Related]
65. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. Jackson G; Atkinson L; Oram S Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952 [TBL] [Abstract][Full Text] [Related]
66. Combined propranolol and digoxin therapy in angina pectoris. Crawford MH; LeWinter MM; O'Rourke RA; Karliner JS; Ross J Ann Intern Med; 1975 Oct; 83(4):449-55. PubMed ID: 1101757 [TBL] [Abstract][Full Text] [Related]
67. Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise. Nesto RW; White HD; Ganz P; Koslowski J; Wynne J; Holman BL; Antman E Am J Cardiol; 1985 May; 55(12):3E-8E. PubMed ID: 3923813 [TBL] [Abstract][Full Text] [Related]
68. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris. Jones GR; Mir MA Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104 [TBL] [Abstract][Full Text] [Related]
69. [Comparative study of the effectiveness of average therapeutic doses of sustac and obzidan in patients with exertional angina pectoris]. Nazarenko VA; Savvateev KL; Mazur NA Kardiologiia; 1982 Sep; 22(9):42-6. PubMed ID: 6815367 [No Abstract] [Full Text] [Related]
70. Clinical response and effects on left ventricular function of isosorbide dinitrate added to propranolol or diltiazem monotherapy in patients with chronic stable angina. Humen DP; Kostuk WJ Can J Cardiol; 1991 Mar; 7(2):74-80. PubMed ID: 2049686 [TBL] [Abstract][Full Text] [Related]
71. Superiority of combined diltiazem and propranolol therapy for angina pectoris. Strauss WE; Parisi AF Circulation; 1985 May; 71(5):951-7. PubMed ID: 3921278 [TBL] [Abstract][Full Text] [Related]
72. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195 [TBL] [Abstract][Full Text] [Related]
73. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. Gottlieb SO; Weisfeldt ML; Ouyang P; Achuff SC; Baughman KL; Traill TA; Brinker JA; Shapiro EP; Chandra NC; Mellits ED Circulation; 1986 Feb; 73(2):331-7. PubMed ID: 3510764 [TBL] [Abstract][Full Text] [Related]
74. Controlled clinical trial of propranolol alone and in combination with dilazep in patients with angina pectoris. Biswas NR; Pandhi P; Wahi PL; Sharma PL Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):241-4. PubMed ID: 2198233 [TBL] [Abstract][Full Text] [Related]
75. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine. Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181 [TBL] [Abstract][Full Text] [Related]
76. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Hebb AR; Godwin TF; Gunn RW Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821 [No Abstract] [Full Text] [Related]
77. The time of onset of action of sublingual nitroglycerin in exercise-induced angina pectoris. A methodological study. Nyberg G Eur Heart J; 1985 Jul; 6(7):625-30. PubMed ID: 3930248 [TBL] [Abstract][Full Text] [Related]
78. Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol. Robinson K; Krikler S; Krikler DM Am J Cardiol; 1989 Sep; 64(11):27F-30F. PubMed ID: 2782269 [TBL] [Abstract][Full Text] [Related]
79. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]